These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

202 related items for PubMed ID: 31804953

  • 1. Clinical evaluation of capillary B-type natriuretic peptide testing.
    Schreinlechner M, Mrakovic A, Laschober G, Mayerl C, Griesmacher A, van Lippen L, Semjonow V, Nieuwenhuis J, van Reenen A, Mair J.
    Clin Chem Lab Med; 2020 Mar 26; 58(4):618-624. PubMed ID: 31804953
    [Abstract] [Full Text] [Related]

  • 2. Amino-terminal pro-B-type natriuretic peptide and B-type natriuretic peptide in the general community: determinants and detection of left ventricular dysfunction.
    Costello-Boerrigter LC, Boerrigter G, Redfield MM, Rodeheffer RJ, Urban LH, Mahoney DW, Jacobsen SJ, Heublein DM, Burnett JC.
    J Am Coll Cardiol; 2006 Jan 17; 47(2):345-53. PubMed ID: 16412859
    [Abstract] [Full Text] [Related]

  • 3. Head to head comparison of N-terminal pro-B-type natriuretic peptide and B-type natriuretic peptide in patients with/without left ventricular systolic dysfunction.
    Vanderheyden M, Bartunek, Claeys G, Manoharan G, Beckers JF, Ide L.
    Clin Biochem; 2006 Jun 17; 39(6):640-5. PubMed ID: 16516185
    [Abstract] [Full Text] [Related]

  • 4. Head-to-head comparison of N-terminal pro-brain natriuretic peptide, brain natriuretic peptide and N-terminal pro-atrial natriuretic peptide in diagnosing left ventricular dysfunction.
    Hammerer-Lercher A, Neubauer E, Müller S, Pachinger O, Puschendorf B, Mair J.
    Clin Chim Acta; 2001 Aug 20; 310(2):193-7. PubMed ID: 11498085
    [Abstract] [Full Text] [Related]

  • 5. Pro-B-type natriuretic peptide levels in acute decompensated heart failure.
    Waldo SW, Beede J, Isakson S, Villard-Saussine S, Fareh J, Clopton P, Fitzgerald RL, Maisel AS.
    J Am Coll Cardiol; 2008 May 13; 51(19):1874-82. PubMed ID: 18466803
    [Abstract] [Full Text] [Related]

  • 6. Plasma N-terminal pro-brain natriuretic peptide and brain natriuretic peptide in assessment of acute dyspnea.
    Alibay Y, Beauchet A, El Mahmoud R, Schmitt C, Brun-Ney D, Benoit MO, Dubourg O, Boileau C, Jondeau G, Puy H.
    Biomed Pharmacother; 2005 May 13; 59(1-2):20-4. PubMed ID: 15740931
    [Abstract] [Full Text] [Related]

  • 7. The Molar Ratio of N-terminal pro-B-type Natriuretic Peptide/B-type Natriuretic Peptide for Heart Failure-related Events in Stable Outpatients with Cardiovascular Risk Factors.
    Suzuki S, Sugiyama S.
    Intern Med; 2018 Sep 15; 57(18):2621-2630. PubMed ID: 29709934
    [Abstract] [Full Text] [Related]

  • 8. The diagnostic accuracy and utility of a B-type natriuretic peptide test in a community population of patients with suspected heart failure.
    Fuat A, Murphy JJ, Hungin AP, Curry J, Mehrzad AA, Hetherington A, Johnston JI, Smellie WS, Duffy V, Cawley P.
    Br J Gen Pract; 2006 May 15; 56(526):327-33. PubMed ID: 16638247
    [Abstract] [Full Text] [Related]

  • 9. Diagnostic accuracy of B type natriuretic peptide and amino terminal proBNP in the emergency diagnosis of heart failure.
    Mueller T, Gegenhuber A, Poelz W, Haltmayer M.
    Heart; 2005 May 15; 91(5):606-12. PubMed ID: 15831643
    [Abstract] [Full Text] [Related]

  • 10. Predictive value of B-type natriuretic peptides in detecting latent left ventricular diastolic dysfunction in beta-thalassemia major.
    Kremastinos DT, Hamodraka E, Parissis J, Tsiapras D, Dima K, Maisel A.
    Am Heart J; 2010 Jan 15; 159(1):68-74. PubMed ID: 20102869
    [Abstract] [Full Text] [Related]

  • 11. PATHFAST NT-proBNP (N-terminal-pro B type natriuretic peptide): a multicenter evaluation of a new point-of-care assay.
    Zaninotto M, Mion MM, Di Serio F, Caputo M, Ottomano C, Plebani M.
    Clin Chem Lab Med; 2010 Jul 15; 48(7):1029-34. PubMed ID: 20406130
    [Abstract] [Full Text] [Related]

  • 12. Biochemical diagnosis of impaired left ventricular ejection fraction--comparison of the diagnostic accuracy of brain natriuretic peptide (BNP) and amino terminal proBNP (NT-proBNP).
    Mueller T, Gegenhuber A, Poelz W, Haltmayer M.
    Clin Chem Lab Med; 2004 Feb 15; 42(2):159-63. PubMed ID: 15061354
    [Abstract] [Full Text] [Related]

  • 13. NT-proBNP and BNP values in cardiac patients with different degree of left ventricular systolic dysfunction.
    Kotaska K, Popelova J, Tiserova M, Telekes P, Vrzanova M, Bronsky J, Halacova M, Kukacka J, Prusa R.
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2006 Jul 15; 150(1):125-30. PubMed ID: 16936915
    [Abstract] [Full Text] [Related]

  • 14. [Diagnostic value of the currently used criteria and brain natriuretic peptide for diagnosing congestive heart failure in children with congenital heart disease].
    Wu YR, Chen SB, Sun K, Huang MR, Zhang YQ, Chen S.
    Zhonghua Er Ke Za Zhi; 2006 Oct 15; 44(10):728-32. PubMed ID: 17229370
    [Abstract] [Full Text] [Related]

  • 15. Natriuretic peptides as markers of mild forms of left ventricular dysfunction: effects of assays on diagnostic performance of markers.
    Hammerer-Lercher A, Ludwig W, Falkensammer G, Müller S, Neubauer E, Puschendorf B, Pachinger O, Mair J.
    Clin Chem; 2004 Jul 15; 50(7):1174-83. PubMed ID: 15142976
    [Abstract] [Full Text] [Related]

  • 16. Pro-brain natriuretic peptide plasma levels, left ventricular dimensions and ejection fraction in acute dyspnoea.
    Shaikh K, Hanif B, Siddique AA, Shaikh MY, Khan MN.
    J Coll Physicians Surg Pak; 2012 Dec 15; 22(12):751-5. PubMed ID: 23217478
    [Abstract] [Full Text] [Related]

  • 17. Combining the use of amino-terminal pro-B-type natriuretic peptide and B-type natriuretic peptide in the prognosis of hospitalized heart failure patients.
    Wang Y, Zhang R, Huang Y, Zhai M, Zhou Q, An T, Huang Y, Zhao X, Tian P, Zhang Y, Zhang J.
    Clin Chim Acta; 2019 Apr 15; 491():8-14. PubMed ID: 30594544
    [Abstract] [Full Text] [Related]

  • 18. Alternate circulating pro-B-type natriuretic peptide and B-type natriuretic peptide forms in the general population.
    Lam CS, Burnett JC, Costello-Boerrigter L, Rodeheffer RJ, Redfield MM.
    J Am Coll Cardiol; 2007 Mar 20; 49(11):1193-202. PubMed ID: 17367664
    [Abstract] [Full Text] [Related]

  • 19. [Values of brain natriuretic peptide and N-terminal pro-brain natriuretic peptide in evaluation of cardiac function in children with congenital heart disease].
    Zhang SR, Zhang YH, Xu Q, Qiu HX, Chen Q.
    Zhongguo Dang Dai Er Ke Za Zhi; 2009 Jun 20; 11(6):429-32. PubMed ID: 19558803
    [Abstract] [Full Text] [Related]

  • 20. Direct comparison of B-type natriuretic peptide (BNP) and amino-terminal proBNP in a large population of patients with chronic and symptomatic heart failure: the Valsartan Heart Failure (Val-HeFT) data.
    Masson S, Latini R, Anand IS, Vago T, Angelici L, Barlera S, Missov ED, Clerico A, Tognoni G, Cohn JN, Val-HeFT Investigators.
    Clin Chem; 2006 Aug 20; 52(8):1528-38. PubMed ID: 16777915
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.